Anzeige
Mehr »
Montag, 07.07.2025 - Börsentäglich über 12.000 News
Surfen Sie die heißeste Edelmetall-Welle des Jahrzehnts! Dieses TOP-Unternehmen zündet nächste Wachstumsstufe!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
169 Leser
Artikel bewerten:
(0)

BioLumic Appoints Steve Sibulkin as CEO

Proven Ag and Tech Leader to Drive Photogenics Company's Continued Product Development Efforts and Global Growth

NEW YORK and PALMERSTON NORTH, New Zealand, June 08, 2020 Ltd. ("BioLumic"), the leader in using plant photogenics to unlock the genetic potential of seeds and seedlings, today announced the appointment of Steve Sibulkin as Chief Executive Officer. Based on decades of experience in the agriculture and technology industries, Sibulkin will lead the company's global expansion and accelerate its UV light treatment innovation based on the groundbreaking BioLumic photogenics platform.

"An exceptional sustainable agriculture innovator tackling complex farming challenges, BioLumic is at a critical juncture as it prepares for the immense opportunities ahead and the rigors of global commercialization," noted Dr. Adrian Percy, BioLumic Chairman of the Board and CTO of UPL Ltd. "With a proven track record building industry leading ag and tech companies, Steve will help BioLumic move faster and deepen relationships with key partners, while accelerating the company's ability to bring its innovations to the market."

Sibulkin joins BioLumic from Yara International, where he led enterprise sustainability, partnership and digital initiatives after the company acquired the precision agriculture company he co-founded, Agronomic Technology Corp (ATC), in 2017. As the CEO of ATC, Sibulkin commercialized and grew the Adapt-N nitrogen recommendation solution, which was originally developed by a team at Cornell University. Under his leadership, ATC conducted over one billion simulations, expanded its product portfolio, signed enterprise partners, and became an industry-standard with growers, agriculture industry leaders and sustainably focused organizations. Before joining Yara, Sibulkin was a multi-time CEO, entrepreneur and strategic advisor, and held leadership positions at Sapient, Ogilvy & Mather, and Mainspring.

"BioLumic's discoveries around plant signaling responses harness the natural genetic potential of seeds and seedlings for yield improvement, disease resistance and the ability to withstand environmental stress - all without requiring additional inputs or genetic modification. This is a huge win for farmer profitability, the food and agriculture supply chain and the environment," said Sibulkin. "BioLumic perfectly aligns with the movement toward more resilient and productive agriculture, and the opportunity to accelerate the growth of this transformative technology is one I couldn't resist."

Rooted in more than a decade of research into UV light treatments in plants and spun out from Massey University in New Zealand, BioLumic's proven technology offers seed producers and growers new opportunities to grow more valuable and sustainable crops. Its scientifically validated photogenics platform uses a combination of artificial intelligence and precise light treatments to activate the natural plant signaling response to UV light, triggering plant growth that enhances crop yield, crop quality, drought tolerance, and natural disease and pest resistance.

"Our proprietary technology cultivates stronger, healthier plants to meet rising food demands, and we are ready to focus on commercialization and building a global footprint," added Dr. Jason Wargent, founder and chief science officer. "A respected leader in sustainable agriculture, Steve's wealth of experience leading cross-disciplinary teams around new categories of product innovation will help drive the adoption of our novel light treatments in the global ag marketplace."

Positive outcomes from produce such as broccoli, lettuce, strawberries and tomatoes have accelerated the development of BioLumic's high-quality seed and plant treatment innovations for indoor farming, row crops like soybeans, and high-value crops like cannabis. BioLumic is actively growing its team to support the acceleration and expansion of its UV light treatment initiatives.

"With recent trials showing the extensibility of this novel technology across crops, we know growers around the globe will see improved profit from their seed and seedling investments," added Sibulkin. "Our next step involves deepening our partnerships with seed companies, seed dealers, sustainability-focused organizations and enterprises that have aligned interest in utilizing and expanding this technology."

Sibulkin earned a B.A. in political science from UCLA and an MBA from Kellogg Graduate School of Management, where he graduated with Beta Gamma Sigma distinction and co-founded the Net Impact Chapter. He currently resides in New York City.

About BioLumic
BioLumic harnesses the power of ultraviolet.

© 2020 GlobeNewswire (Europe)
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.